Cancer Cachexia Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Therapeutics (Progestogens, Corticosteroids, Combination Therapies, Others); Mechanism of Action (Appetite Stimulators, Weight Loss Stabilizers, Others); Distribution Channel (Hospital Stores, Retail Pharmacy Store, Online Pharmacy) and Geography
Report Code: TIPRE00005209 No. of Pages: 156 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Cachexia or wasting syndrome is a condition of extreme weight loss and muscles atrophy, fatigue, weakness and loss of appetite due to the severe chronic illness. The cachexia is observed in the people suffering from chronic diseases like cancer, AIDS, multiple sclerosis, tuberculosis, Crohn's disease and others. The pathogenicity of cancer cachexia is multifactorial because of its complex interaction between host and tumor. Mostly patients suffer from cancer cachexia due to the starvation weight loss, excess expenditure of energy by body and anemia.
MARKET DYNAMICS
The cancer cachexia market is expected to grow exponentially owing to driving factors such as increase in prevalence of cachexia and rising number of pipeline product for the treatment of cancer cachexia. However lack of awareness among population regarding cachexia cancer and long procedure for FDA approval are expected to impede the market growth.
MARKET SCOPE
The "Global Cancer Cachexia Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of cancer cachexia market with detailed market segmentation by therapeutics, mechanism of action, distribution channel and geography. The global cancer cachexia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cancer cachexia market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cancer cachexia market is segmented on the basis of therapeutics, mechanism of action and distribution channel. Based on therapeutics, the market is segmented as progestogens, corticosteroids, combination therapies and others. Based on mechanism of action the cancer cachexia market is segmented as appetite stimulators, weight loss stabilizers and others. On the basis of distribution channel the market is segmented as hospital stores, retail pharmacy store and online pharmacy.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer cachexia market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer cachexia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cancer cachexia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cancer cachexia market in these regions.
MARKET PLAYERS
The reports cover key developments in the cancer cachexia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cancer cachexia market are anticipated to lucrative growth opportunities in the future with the rising demand for cancer cachexia in the global market. Below mentioned is the list of few companies engaged in the cancer cachexia market.
The report also includes the profiles of key cancer cachexia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Cachexia or wasting syndrome is a condition of extreme weight loss and muscles atrophy, fatigue, weakness and loss of appetite due to the severe chronic illness. The cachexia is observed in the people suffering from chronic diseases like cancer, AIDS, multiple sclerosis, tuberculosis, Crohn's disease and others. The pathogenicity of cancer cachexia is multifactorial because of its complex interaction between host and tumor. Mostly patients suffer from cancer cachexia due to the starvation weight loss, excess expenditure of energy by body and anemia.
MARKET DYNAMICS
The cancer cachexia market is expected to grow exponentially owing to driving factors such as increase in prevalence of cachexia and rising number of pipeline product for the treatment of cancer cachexia. However lack of awareness among population regarding cachexia cancer and long procedure for FDA approval are expected to impede the market growth.
MARKET SCOPE
The "Global Cancer Cachexia Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of cancer cachexia market with detailed market segmentation by therapeutics, mechanism of action, distribution channel and geography. The global cancer cachexia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cancer cachexia market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cancer cachexia market is segmented on the basis of therapeutics, mechanism of action and distribution channel. Based on therapeutics, the market is segmented as progestogens, corticosteroids, combination therapies and others. Based on mechanism of action the cancer cachexia market is segmented as appetite stimulators, weight loss stabilizers and others. On the basis of distribution channel the market is segmented as hospital stores, retail pharmacy store and online pharmacy.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer cachexia market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer cachexia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cancer cachexia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cancer cachexia market in these regions.
MARKET PLAYERS
The reports cover key developments in the cancer cachexia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cancer cachexia market are anticipated to lucrative growth opportunities in the future with the rising demand for cancer cachexia in the global market. Below mentioned is the list of few companies engaged in the cancer cachexia market.
The report also includes the profiles of key cancer cachexia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Æterna Zentaris Inc.
- ALDER BIOPHARMACEUTICALS, INC
- Aphios
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GTx, Inc.
- Helsinn Healthcare SA.
- Merck Sharp & Dohme Corp. (Merck & Co., Inc)
- Novartis AG
- XBiotech, Inc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Cachexia Market - By Therapeutics
1.3.2 Cancer Cachexia Market - By Mechanism of Action
1.3.3 Cancer Cachexia Market - By Distribution Channel
1.3.4 Cancer Cachexia Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANCER CACHEXIA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER CACHEXIA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CANCER CACHEXIA MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER CACHEXIA - GLOBAL MARKET OVERVIEW
6.2. CANCER CACHEXIA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CANCER CACHEXIA MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. PROGESTOGENS
7.3.1. Overview
7.3.2. Progestogens Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.5. COMBINATION THERAPIES
7.5.1. Overview
7.5.2. Combination Therapies Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. CANCER CACHEXIA MARKET - REVENUE AND FORECASTS TO 2027 - MECHANISM OF ACTION
8.1. OVERVIEW
8.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
8.3. APPETITE STIMULATORS
8.3.1. Overview
8.3.2. Appetite Stimulators Market Forecast and Analysis
8.4. WEIGHT LOSS STABILIZERS
8.4.1. Overview
8.4.2. Weight Loss Stabilizers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CANCER CACHEXIA MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL STORES
9.3.1. Overview
9.3.2. Hospital Stores Market Forecast and Analysis
9.4. RETAIL PHARMACY STORE
9.4.1. Overview
9.4.2. Retail Pharmacy Store Market Forecast and Analysis
9.5. ONLINE PHARMACY
9.5.1. Overview
9.5.2. Online Pharmacy Market Forecast and Analysis
10. CANCER CACHEXIA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cancer Cachexia Market Overview
10.1.2 North America Cancer Cachexia Market Forecasts and Analysis
10.1.3 North America Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.1.4 North America Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.1.5 North America Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Cancer Cachexia Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cancer Cachexia Market
10.1.6.1.1 United States Cancer Cachexia Market by Therapeutics
10.1.6.1.2 United States Cancer Cachexia Market by Mechanism of Action
10.1.6.1.3 United States Cancer Cachexia Market by Distribution Channel
10.1.6.2 Canada Cancer Cachexia Market
10.1.6.2.1 Canada Cancer Cachexia Market by Therapeutics
10.1.6.2.2 Canada Cancer Cachexia Market by Mechanism of Action
10.1.6.2.3 Canada Cancer Cachexia Market by Distribution Channel
10.1.6.3 Mexico Cancer Cachexia Market
10.1.6.3.1 Mexico Cancer Cachexia Market by Therapeutics
10.1.6.3.2 Mexico Cancer Cachexia Market by Mechanism of Action
10.1.6.3.3 Mexico Cancer Cachexia Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Cancer Cachexia Market Overview
10.2.2 Europe Cancer Cachexia Market Forecasts and Analysis
10.2.3 Europe Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.2.4 Europe Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.2.5 Europe Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Cancer Cachexia Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cancer Cachexia Market
10.2.6.1.1 Germany Cancer Cachexia Market by Therapeutics
10.2.6.1.2 Germany Cancer Cachexia Market by Mechanism of Action
10.2.6.1.3 Germany Cancer Cachexia Market by Distribution Channel
10.2.6.2 France Cancer Cachexia Market
10.2.6.2.1 France Cancer Cachexia Market by Therapeutics
10.2.6.2.2 France Cancer Cachexia Market by Mechanism of Action
10.2.6.2.3 France Cancer Cachexia Market by Distribution Channel
10.2.6.3 Italy Cancer Cachexia Market
10.2.6.3.1 Italy Cancer Cachexia Market by Therapeutics
10.2.6.3.2 Italy Cancer Cachexia Market by Mechanism of Action
10.2.6.3.3 Italy Cancer Cachexia Market by Distribution Channel
10.2.6.4 Spain Cancer Cachexia Market
10.2.6.4.1 Spain Cancer Cachexia Market by Therapeutics
10.2.6.4.2 Spain Cancer Cachexia Market by Mechanism of Action
10.2.6.4.3 Spain Cancer Cachexia Market by Distribution Channel
10.2.6.5 United Kingdom Cancer Cachexia Market
10.2.6.5.1 United Kingdom Cancer Cachexia Market by Therapeutics
10.2.6.5.2 United Kingdom Cancer Cachexia Market by Mechanism of Action
10.2.6.5.3 United Kingdom Cancer Cachexia Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cancer Cachexia Market Overview
10.3.2 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis
10.3.3 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.3.4 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.3.5 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cancer Cachexia Market
10.3.6.1.1 Australia Cancer Cachexia Market by Therapeutics
10.3.6.1.2 Australia Cancer Cachexia Market by Mechanism of Action
10.3.6.1.3 Australia Cancer Cachexia Market by Distribution Channel
10.3.6.2 China Cancer Cachexia Market
10.3.6.2.1 China Cancer Cachexia Market by Therapeutics
10.3.6.2.2 China Cancer Cachexia Market by Mechanism of Action
10.3.6.2.3 China Cancer Cachexia Market by Distribution Channel
10.3.6.3 India Cancer Cachexia Market
10.3.6.3.1 India Cancer Cachexia Market by Therapeutics
10.3.6.3.2 India Cancer Cachexia Market by Mechanism of Action
10.3.6.3.3 India Cancer Cachexia Market by Distribution Channel
10.3.6.4 Japan Cancer Cachexia Market
10.3.6.4.1 Japan Cancer Cachexia Market by Therapeutics
10.3.6.4.2 Japan Cancer Cachexia Market by Mechanism of Action
10.3.6.4.3 Japan Cancer Cachexia Market by Distribution Channel
10.3.6.5 South Korea Cancer Cachexia Market
10.3.6.5.1 South Korea Cancer Cachexia Market by Therapeutics
10.3.6.5.2 South Korea Cancer Cachexia Market by Mechanism of Action
10.3.6.5.3 South Korea Cancer Cachexia Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cancer Cachexia Market Overview
10.4.2 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis
10.4.3 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.4.4 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.4.5 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cancer Cachexia Market
10.4.6.1.1 South Africa Cancer Cachexia Market by Therapeutics
10.4.6.1.2 South Africa Cancer Cachexia Market by Mechanism of Action
10.4.6.1.3 South Africa Cancer Cachexia Market by Distribution Channel
10.4.6.2 Saudi Arabia Cancer Cachexia Market
10.4.6.2.1 Saudi Arabia Cancer Cachexia Market by Therapeutics
10.4.6.2.2 Saudi Arabia Cancer Cachexia Market by Mechanism of Action
10.4.6.2.3 Saudi Arabia Cancer Cachexia Market by Distribution Channel
10.4.6.3 U.A.E Cancer Cachexia Market
10.4.6.3.1 U.A.E Cancer Cachexia Market by Therapeutics
10.4.6.3.2 U.A.E Cancer Cachexia Market by Mechanism of Action
10.4.6.3.3 U.A.E Cancer Cachexia Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cancer Cachexia Market Overview
10.5.2 South and Central America Cancer Cachexia Market Forecasts and Analysis
10.5.3 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.5.4 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.5.5 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cancer Cachexia Market
10.5.6.1.1 Brazil Cancer Cachexia Market by Therapeutics
10.5.6.1.2 Brazil Cancer Cachexia Market by Mechanism of Action
10.5.6.1.3 Brazil Cancer Cachexia Market by Distribution Channel
10.5.6.2 Argentina Cancer Cachexia Market
10.5.6.2.1 Argentina Cancer Cachexia Market by Therapeutics
10.5.6.2.2 Argentina Cancer Cachexia Market by Mechanism of Action
10.5.6.2.3 Argentina Cancer Cachexia Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CANCER CACHEXIA MARKET, KEY COMPANY PROFILES
12.1. ÆTERNA ZENTARIS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALDER BIOPHARMACEUTICALS, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. APHIOS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GTX, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. HELSINN HEALTHCARE SA.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK SHARP & DOHME CORP. (MERCK & CO., INC.)
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVARTIS AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. XBIOTECH, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Cachexia Market - By Therapeutics
1.3.2 Cancer Cachexia Market - By Mechanism of Action
1.3.3 Cancer Cachexia Market - By Distribution Channel
1.3.4 Cancer Cachexia Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANCER CACHEXIA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER CACHEXIA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CANCER CACHEXIA MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER CACHEXIA - GLOBAL MARKET OVERVIEW
6.2. CANCER CACHEXIA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CANCER CACHEXIA MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. PROGESTOGENS
7.3.1. Overview
7.3.2. Progestogens Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.5. COMBINATION THERAPIES
7.5.1. Overview
7.5.2. Combination Therapies Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. CANCER CACHEXIA MARKET - REVENUE AND FORECASTS TO 2027 - MECHANISM OF ACTION
8.1. OVERVIEW
8.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
8.3. APPETITE STIMULATORS
8.3.1. Overview
8.3.2. Appetite Stimulators Market Forecast and Analysis
8.4. WEIGHT LOSS STABILIZERS
8.4.1. Overview
8.4.2. Weight Loss Stabilizers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CANCER CACHEXIA MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL STORES
9.3.1. Overview
9.3.2. Hospital Stores Market Forecast and Analysis
9.4. RETAIL PHARMACY STORE
9.4.1. Overview
9.4.2. Retail Pharmacy Store Market Forecast and Analysis
9.5. ONLINE PHARMACY
9.5.1. Overview
9.5.2. Online Pharmacy Market Forecast and Analysis
10. CANCER CACHEXIA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cancer Cachexia Market Overview
10.1.2 North America Cancer Cachexia Market Forecasts and Analysis
10.1.3 North America Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.1.4 North America Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.1.5 North America Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Cancer Cachexia Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cancer Cachexia Market
10.1.6.1.1 United States Cancer Cachexia Market by Therapeutics
10.1.6.1.2 United States Cancer Cachexia Market by Mechanism of Action
10.1.6.1.3 United States Cancer Cachexia Market by Distribution Channel
10.1.6.2 Canada Cancer Cachexia Market
10.1.6.2.1 Canada Cancer Cachexia Market by Therapeutics
10.1.6.2.2 Canada Cancer Cachexia Market by Mechanism of Action
10.1.6.2.3 Canada Cancer Cachexia Market by Distribution Channel
10.1.6.3 Mexico Cancer Cachexia Market
10.1.6.3.1 Mexico Cancer Cachexia Market by Therapeutics
10.1.6.3.2 Mexico Cancer Cachexia Market by Mechanism of Action
10.1.6.3.3 Mexico Cancer Cachexia Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Cancer Cachexia Market Overview
10.2.2 Europe Cancer Cachexia Market Forecasts and Analysis
10.2.3 Europe Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.2.4 Europe Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.2.5 Europe Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Cancer Cachexia Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cancer Cachexia Market
10.2.6.1.1 Germany Cancer Cachexia Market by Therapeutics
10.2.6.1.2 Germany Cancer Cachexia Market by Mechanism of Action
10.2.6.1.3 Germany Cancer Cachexia Market by Distribution Channel
10.2.6.2 France Cancer Cachexia Market
10.2.6.2.1 France Cancer Cachexia Market by Therapeutics
10.2.6.2.2 France Cancer Cachexia Market by Mechanism of Action
10.2.6.2.3 France Cancer Cachexia Market by Distribution Channel
10.2.6.3 Italy Cancer Cachexia Market
10.2.6.3.1 Italy Cancer Cachexia Market by Therapeutics
10.2.6.3.2 Italy Cancer Cachexia Market by Mechanism of Action
10.2.6.3.3 Italy Cancer Cachexia Market by Distribution Channel
10.2.6.4 Spain Cancer Cachexia Market
10.2.6.4.1 Spain Cancer Cachexia Market by Therapeutics
10.2.6.4.2 Spain Cancer Cachexia Market by Mechanism of Action
10.2.6.4.3 Spain Cancer Cachexia Market by Distribution Channel
10.2.6.5 United Kingdom Cancer Cachexia Market
10.2.6.5.1 United Kingdom Cancer Cachexia Market by Therapeutics
10.2.6.5.2 United Kingdom Cancer Cachexia Market by Mechanism of Action
10.2.6.5.3 United Kingdom Cancer Cachexia Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cancer Cachexia Market Overview
10.3.2 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis
10.3.3 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.3.4 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.3.5 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Cancer Cachexia Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cancer Cachexia Market
10.3.6.1.1 Australia Cancer Cachexia Market by Therapeutics
10.3.6.1.2 Australia Cancer Cachexia Market by Mechanism of Action
10.3.6.1.3 Australia Cancer Cachexia Market by Distribution Channel
10.3.6.2 China Cancer Cachexia Market
10.3.6.2.1 China Cancer Cachexia Market by Therapeutics
10.3.6.2.2 China Cancer Cachexia Market by Mechanism of Action
10.3.6.2.3 China Cancer Cachexia Market by Distribution Channel
10.3.6.3 India Cancer Cachexia Market
10.3.6.3.1 India Cancer Cachexia Market by Therapeutics
10.3.6.3.2 India Cancer Cachexia Market by Mechanism of Action
10.3.6.3.3 India Cancer Cachexia Market by Distribution Channel
10.3.6.4 Japan Cancer Cachexia Market
10.3.6.4.1 Japan Cancer Cachexia Market by Therapeutics
10.3.6.4.2 Japan Cancer Cachexia Market by Mechanism of Action
10.3.6.4.3 Japan Cancer Cachexia Market by Distribution Channel
10.3.6.5 South Korea Cancer Cachexia Market
10.3.6.5.1 South Korea Cancer Cachexia Market by Therapeutics
10.3.6.5.2 South Korea Cancer Cachexia Market by Mechanism of Action
10.3.6.5.3 South Korea Cancer Cachexia Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cancer Cachexia Market Overview
10.4.2 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis
10.4.3 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.4.4 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.4.5 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Cancer Cachexia Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cancer Cachexia Market
10.4.6.1.1 South Africa Cancer Cachexia Market by Therapeutics
10.4.6.1.2 South Africa Cancer Cachexia Market by Mechanism of Action
10.4.6.1.3 South Africa Cancer Cachexia Market by Distribution Channel
10.4.6.2 Saudi Arabia Cancer Cachexia Market
10.4.6.2.1 Saudi Arabia Cancer Cachexia Market by Therapeutics
10.4.6.2.2 Saudi Arabia Cancer Cachexia Market by Mechanism of Action
10.4.6.2.3 Saudi Arabia Cancer Cachexia Market by Distribution Channel
10.4.6.3 U.A.E Cancer Cachexia Market
10.4.6.3.1 U.A.E Cancer Cachexia Market by Therapeutics
10.4.6.3.2 U.A.E Cancer Cachexia Market by Mechanism of Action
10.4.6.3.3 U.A.E Cancer Cachexia Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cancer Cachexia Market Overview
10.5.2 South and Central America Cancer Cachexia Market Forecasts and Analysis
10.5.3 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Therapeutics
10.5.4 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Mechanism of Action
10.5.5 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Cancer Cachexia Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cancer Cachexia Market
10.5.6.1.1 Brazil Cancer Cachexia Market by Therapeutics
10.5.6.1.2 Brazil Cancer Cachexia Market by Mechanism of Action
10.5.6.1.3 Brazil Cancer Cachexia Market by Distribution Channel
10.5.6.2 Argentina Cancer Cachexia Market
10.5.6.2.1 Argentina Cancer Cachexia Market by Therapeutics
10.5.6.2.2 Argentina Cancer Cachexia Market by Mechanism of Action
10.5.6.2.3 Argentina Cancer Cachexia Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CANCER CACHEXIA MARKET, KEY COMPANY PROFILES
12.1. ÆTERNA ZENTARIS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALDER BIOPHARMACEUTICALS, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. APHIOS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GTX, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. HELSINN HEALTHCARE SA.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK SHARP & DOHME CORP. (MERCK & CO., INC.)
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVARTIS AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. XBIOTECH, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Æterna Zentaris Inc.
2. ALDER BIOPHARMACEUTICALS, INC
3. Aphios
4. Bristol-Myers Squibb Company
5. Eli Lilly and Company
6. GTx, Inc.
7. Helsinn Healthcare SA.
8. Merck Sharp & Dohme Corp. (Merck & Co., Inc)
9. Novartis AG
10. XBiotech, Inc.
1. Æterna Zentaris Inc.
2. ALDER BIOPHARMACEUTICALS, INC
3. Aphios
4. Bristol-Myers Squibb Company
5. Eli Lilly and Company
6. GTx, Inc.
7. Helsinn Healthcare SA.
8. Merck Sharp & Dohme Corp. (Merck & Co., Inc)
9. Novartis AG
10. XBiotech, Inc.